Cargando…

Cylindromatosis Lysine 63 Deubiquitinase (CYLD) Regulates NF-kB Signaling Pathway and Modulates Fibroblast and Endothelial Cells Recruitment in Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is a malignant epithelial carcinoma of the nasopharynx. Cylindromatosis lysine 63 deubiquitinase (CYLD), a NF-kB inhibitor, was reported as one of the top mutated candidate genes in NPC. NF-kB is an inducible transcription factor, contributing to cancer via regulating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Mingdan, Dai, Wei, Yu, Valen Zhuoyou, Tao, Lihua, Lung, Maria Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409113/ https://www.ncbi.nlm.nih.gov/pubmed/32708712 http://dx.doi.org/10.3390/cancers12071924

Ejemplares similares

The cylindromatosis (CYLD) gene and head and neck tumorigenesis
por: Verhoeft, Krista Roberta, et al.
Publicado: (2016)

Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis
por: van den Ouweland, Ans M. W., et al.
Publicado: (2010)

CaMKII Mediates Recruitment and Activation of the Deubiquitinase CYLD at the Postsynaptic Density
por: Thein, Soe, et al.
Publicado: (2014)

The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate Notch signalling
por: Rajan, Neil, et al.
Publicado: (2014)

Correction: CaMKII Mediates Recruitment and Activation of the Deubiquitinase CYLD at the Postsynaptic Density
Publicado: (2014)

<i>CYLD</i> GeneticTesting for Brooke-Spiegler Syndrome, Familial Cylindromatosis and Multiple Familial Trichoepitheliomas
por: Dubois, Anna, et al.
Publicado: (2015)

The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation
por: Huang, Zhenzhou, et al.
Publicado: (2023)

TRIM15 and CYLD regulate ERK activation via lysine 63-linked polyubiquitination
por: Zhu, Guixin, et al.
Publicado: (2021)

Expression of the deubiquitinase cylindromatosis in articular cartilage and subchondral bone is associated with the severity of knee osteoarthritis
por: Hong, Liu, et al.
Publicado: (2017)

Mutual regulation between deubiquitinase CYLD and retroviral oncoprotein Tax
por: Wu, Xuefeng, et al.
Publicado: (2011)

Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy
por: Guo, Jianying, et al.
Publicado: (2014)

CYLD Deubiquitinase Negatively Regulates High Glucose-Induced NF-κB Inflammatory Signaling in Mesangial Cells
por: Li, Yanhui, et al.
Publicado: (2017)

The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway
por: Zhang, Lele, et al.
Publicado: (2018)

Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD
por: Komatsu, Kensei, et al.
Publicado: (2013)

Nuclear Expression of the Deubiquitinase CYLD Is Associated with Improved Survival in Human Hepatocellular Carcinoma
por: Welte, Stefan, et al.
Publicado: (2014)

SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes
por: Kupka, Sebastian, et al.
Publicado: (2016)

The E3 ligase Itch and deubiquitinase Cyld co-operatively regulate Tak1 and inflammation
por: Ahmed, Neesar, et al.
Publicado: (2011)

CYLD Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Regulating NDRG1
por: Lin, Yanling, et al.
Publicado: (2020)

Down-regulated cylindromatosis enhances NF-κB activation and aggravates inflammation in HBV-ACLF patients
por: Zhang, Xueyun, et al.
Publicado: (2022)

Expression of CYLD and NF-κB in Human Cholesteatoma Epithelium
por: Byun, Jae Yong, et al.
Publicado: (2010)

Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency
por: Bekas, Nikolaos, et al.
Publicado: (2023)

Cylindromatosis mediates neuronal cell death in vitro and in vivo
por: Ganjam, Goutham K., et al.
Publicado: (2018)

Cylindromatosis Is Required for Survival of a Subset of Melanoma Cells
por: La, Ting, et al.
Publicado: (2020)

Gain-of-function hot spot mutant p53(R248Q) regulation of integrin/FAK/ERK signaling in esophageal squamous cell carcinoma
por: Yu, Valen Zhuoyou, et al.
Publicado: (2020)

The CYLD p.R758X worldwide recurrent nonsense mutation detected in patients with multiple familial trichoepithelioma type 1, Brooke-Spiegler syndrome and familial cylindromatosis represents a mutational hotspot in the gene
por: Farkas, Katalin, et al.
Publicado: (2016)

Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial
por: Cranston, Amy, et al.
Publicado: (2017)

The Deubiquitinase CYLD Targets Smad7 Protein to Regulate Transforming Growth Factor β (TGF-β) Signaling and the Development of Regulatory T Cells
por: Zhao, Yongge, et al.
Publicado: (2011)

Familial Dermal Eccrine Cylindromatosis with Emphasis on Histology and Genetic Mapping
por: Dhir, G, et al.
Publicado: (2013)

The surgical treatment of familial cylindromatosis through subgaleal scalp excision
por: Karalija, Amar, et al.
Publicado: (2015)

miR-197-3p-induced downregulation of lysine 63 deubiquitinase promotes cell proliferation and inhibits cell apoptosis in lung adenocarcinoma cell lines
por: Chen, Yang, et al.
Publicado: (2018)

Structural basis of SETD6-mediated regulation of the NF-kB network via methyl-lysine signaling
por: Chang, Yanqi, et al.
Publicado: (2011)

An siRNA library screen identifies CYLD and USP34 as deubiquitinases that regulate GPCR-p38 MAPK signaling and distinct inflammatory responses
por: Cheng, Norton, et al.
Publicado: (2023)

CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling
por: Hrdinka, Matous, et al.
Publicado: (2016)

p63 and smooth muscle actin expression in low‐grade spiradenocarcinomas in a case of CYLD cutaneous syndrome
por: Hoyle, Aoisha, et al.
Publicado: (2018)

CYLD in health and disease
por: Marín-Rubio, José L., et al.
Publicado: (2023)

CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation
por: Zhang, Le-meng, et al.
Publicado: (2018)

SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling
por: Elliott, Paul R., et al.
Publicado: (2016)

Electroacupuncture Suppresses the NF-κB Signaling Pathway by Upregulating Cylindromatosis to Alleviate Inflammatory Injury in Cerebral Ischemia/Reperfusion Rats
por: Jiang, Jin, et al.
Publicado: (2017)

NF-kB and the CLL microenvironment
por: O’Donnell, Alice, et al.
Publicado: (2023)

CYLD and SUMO in neuroblastoma therapy
por: Masoumi, Katarzyna Chmielarska, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l3g0pjv2s120bsqk5njenakd5q